BioClinica bags $30M in Big Pharma deals

CRO BioClinica said it inked two long-term deals with major drugmakers totaling $30 million, touting its eClinical technology as driving sponsor interest. Without disclosing its clients, BioClinica said each deal was the product of an earlier collaboration in which the company's platform of software-based offerings won it a follow-on contract. After going through two mergers in as many years, the Newtown, PA, CRO is working to diversify its technology by expanding into imaging and patient recruitment. More

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.